Form 4: UnitedHealth Group Director Kristen Gil Reports Stock Acquisitions
SEC Form 4 Filing
Director Kristen Gil reports acquisition of UnitedHealth Group common stock and deferred stock units as part of regular quarterly compensation.
Summary
- Kristen Gil, a director of UnitedHealth Group, reported acquiring 114 deferred stock units and 64 shares of common stock on July 1, 2024.
- The acquisitions are part of regular quarterly compensation for service as a director.
- The deferred stock units are immediately vested but must be retained until completion of service on the Board.
- Following the reported transactions, Gil directly owns 1,043 shares of common stock and indirectly owns 110 shares via a trust.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of director compensation.
Positives
- The acquisitions reflect ongoing compensation for a director's service, indicating continued engagement and alignment with the company's interests.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading and provide investors with information about the transactions of company insiders.
Stakeholder Impact
- The disclosure provides transparency to shareholders regarding director compensation.
Key Dates
| Date | Description |
|---|---|
| 07/01/2024 | Date of stock and deferred stock unit acquisition |
| 07/02/2024 | Date of Faraz A. Choudhry's signature as Attorney-in-Fact for Kristen L. Gil |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.